Variable | Patient no. | LFS (%) | p | NFS (%) | p | LRFS (%) | p | DMFS (%) | p | PFS (%) | p | OS (%) | p |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Both CLNs and RLNs | |||||||||||||
Yes | 77 | 77.2 | 0.068 | 78.4 | 0.112 | 74.6 | 0.034 | 72.5 | 0.004 | 65.5 | 0.003 | 85.3 | 0.119 |
No | 65 | 87.1 | 87.3 | 87.3 | 95.2 | 87.4 | 95.1 | ||||||
Size of CLNs | |||||||||||||
CLN ≤ 3 cm | 66 | 81.0 | 0.988 | 83.5 | 0.940 | 80.5 | 0.966 | 79.8 | 0.426 | 74.0 | 0.448 | 88.8 | 0.853 |
CLN 3-6 cm | 44 | 74.1 | 74.0 | 72.2 | 76.0 | 64.7 | 87.2 | ||||||
Number of CLNs | |||||||||||||
Single CLN | 62 | 73.9 | 0.328 | 74.1 | 0.174 | 70.7 | 0.154 | 71.5 | 0.240 | 60.3 | 0.132 | 85.6 | 0.562 |
Multiple CLNs | 48 | 84.8 | 86.4 | 84.8 | 86.7 | 81.2 | 90.5 | ||||||
Age | |||||||||||||
<50 | 74 | 83.8 | 0.858 | 84.8 | 0.683 | 82.4 | 0.881 | 81.3 | 0.649 | 77.4 | 0.802 | 89.9 | 0.542 |
>50 | 68 | 81.0 | 81.3 | 79.8 | 83.0 | 74.0 | 88.9 | ||||||
Sex | |||||||||||||
Male | 106 | 79.5 | 0.215 | 80.6 | 0.215 | 78.9 | 0.355 | 77.0 | 0.066 | 70.6 | 0.114 | 86.9 | 0.123 |
Female | 36 | 89.3 | 89.0 | 86.3 | 94.3 | 86.3 | 97.1 | ||||||
Radiotherapy | |||||||||||||
2D-RT | 35 | 77.5 | 0.263 | 80.5 | 0.526 | 75.2 | 0.207 | 66.7 | 0.009 | 62.4 | 0.027 | 83.0 | 0.160 |
IMRT | 107 | 83.2 | 83.0 | 82.1 | 89.5 | 80.5 | 92.7 | ||||||
Chemotherapy | |||||||||||||
Yes | 16 | 92.3 | 0.379 | 84.6 | 0.995 | 84.6 | 0.815 | 85.7 | 0.937 | 77.9 | 0.950 | 92.3 | 0.765 |
No | 126 | 80.7 | 82.4 | 80.2 | 81.5 | 74.4 | 89.4 | ||||||
Pathology | |||||||||||||
WHO II | 37 | 76.2 | 0.238 | 75.1 | 0.167 | 73.0 | 0.171 | 79.3 | 0.347 | 68.7 | 0.183 | 88.1 | 0.473 |
WHO III | 105 | 84.3 | 85.5 | 83.5 | 82.6 | 76.9 | 90.4 | ||||||
T Stage | |||||||||||||
T1-T2 | 85 | 89.6 | 0.032 | 88.5 | 0.165 | 87.3 | 0.097 | 87.8 | 0.005 | 81.6 | 0.012 | 94.7 | 0.048 |
T3-T4 | 57 | 72.5 | 75.7 | 72.6 | 72.5 | 65.4 | 82.4 |